OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

Novartis AG/  US66987V1098  /

Cboe US
2025-05-09  9:59:58 PM Chg. -1.45 Volume Bid10:25:00 PM Ask10:27:26 PM Market Capitalization Dividend Y. P/E Ratio
108.68USD -1.32% 73,162
Turnover: 4.31 mill.		 95.01Bid Size: 1 -Ask Size: - 194.19 bill.USD - -
Newsfile Corp 4:29 PM Delivering a Successful 4th China-Central and Eastern European Countries Expo & International Consum...
GlobeNewswire 05-08 Monte Rosa Therapeutics Announces First Quarter 2025 Financial Results and Business Updates
GlobeNewswire 05-01 Gene Therapy Momentum Builds Among Hematologists in Sickle Cell Disease Management Despite Ongoing A...
TeleTrader 04-30 Novartis to buy Regulus in deal worth up to $1.7B
TeleTrader 04-29 Novartis EPS up 40% to $1.83 in Q1
TeleTrader 04-23 Novartis, Sanofi urge EU to raise prices, warn of industry decline
TeleTrader 04-09 Pharma stocks drop in Europe amid Trump tariff plans
GlobeNewswire 04-02 Grove AI Welcomes Former Novartis, UCB, and Google Executives to Company Advisory Board
GlobeNewswire 03-18 Fabhalta Shakes Up the PNH Market in 15 Months as Soliris, Ultomiris, and Empaveli Compete and Voyde...
GlobeNewswire 03-13 Novartis Pharmaceuticals and Folia Health Partner on Innovative App-Based Study to Assess Real-World...
GlobeNewswire 02-13 Early Launch Metrics Indicate UCB’s Bimzelx (bimekizumab) Poised to Disrupt the U.S. Psoriatic Arthr...
TeleTrader 02-11 Novartis to buy Anthos Therapeutics for up to $3.1B
TeleTrader 01-31 Novartis' Q4 net sales surge 15% to $13.15 billion
TeleTrader 2024-10-29 Novartis' Q2 EPS surge by 116% to $1.58
GlobeNewswire 2024-07-30 Arvinas Reports Second Quarter 2024 Financial Results and Provides Corporate Update
TeleTrader 2024-07-18 Novartis Q2 EPS up 47% to $1.60
GlobeNewswire 2024-07-08 Lexicon Board of Directors Appoints Mike Exton, Ph.D. as New Chief Executive Officer and Director
GlobeNewswire 2024-06-26 As the PNH Market Continues to Crowd, Spherix Announces New Suite of Advisory Services to Explore Co...
GlobeNewswire 2024-06-13 Novartis' Fabhalta Shows Promise in Addressing Critical Gaps in C3 Glomerulopathy Treatment
GlobeNewswire 2024-05-29 Lynch Carpenter Investigates Claims in Cencora, Inc. Data Breach
GlobeNewswire 2024-05-13 Voyager Therapeutics Reports First Quarter 2024 Financial and Operating Results
TeleTrader 2024-05-02 Novartis to acquire Mariana Oncology for $1.7B
TeleTrader 2024-04-23 Novartis up 5% on upbeat guidance, earnings
TeleTrader 2024-04-23 Novartis EPS up 28% to $1.31 in Q1
GlobeNewswire 2024-04-16 Novartis’ Intravenous Formulation of Cosentyx Impacting Prescriber Preferences in Psoriatic Arthriti...